AS

Arvind Shyamnarayan Singh

Active Director Designated Partner DIN 10659436
DIN 10659436 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Arvind Shyamnarayan Singh

Data last updated:

Arvind Shyamnarayan Singh is a Designated Partner at Taiyo Pharmaceutical Llp (since 2024). The company operates in Pharma.

DIN 10659436
Primary Designation Designated Partner
Industry Pharma
First Appointment 06 Jun 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Jun 20242021Active

Board colleagues of Arvind Shyamnarayan Singh

NameDINCompanyDesignation
Shyam Mohan Shukla09402634Taiyo Pharmaceutical LlpDesignated Partner
Vijay Pratap Singh09804855Taiyo Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Taiyo Pharmaceutical Llp
Premium access

Shareholding and investment profile for Arvind Shyamnarayan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Shyamnarayan Singh

Arvind Shyamnarayan Singh currently holds 1 directorship: Taiyo Pharmaceutical Llp (Designated Partner, since 06 Jun 2024).

Arvind Shyamnarayan Singh was first appointed on 06 Jun 2024 as Designated Partner at Taiyo Pharmaceutical Llp.

The current boards of Arvind Shyamnarayan Singh's companies include Shyam Mohan Shukla (Taiyo Pharmaceutical Llp), Vijay Pratap Singh (Taiyo Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available